Prevalence of carotid web in a French cohort of cryptogenic stroke.


Journal

Journal of the neurological sciences
ISSN: 1878-5883
Titre abrégé: J Neurol Sci
Pays: Netherlands
ID NLM: 0375403

Informations de publication

Date de publication:
15 08 2021
Historique:
received: 09 03 2021
revised: 11 05 2021
accepted: 25 05 2021
pubmed: 8 6 2021
medline: 12 8 2021
entrez: 7 6 2021
Statut: ppublish

Résumé

Carotid webs (CaW) may be an under-recognized cause of anterior circulation cryptogenic ischemic stroke (ACIS). Prevalence is still unknown in European patients with ACIS. To evaluate the prevalence of CaW in ACIS and describe patients with CaW phenotype in a cohort of patients from a French stroke center. We conducted a retrospective monocentric cohort study from 01/01/2015 to 31/12/2019 (Montpellier University Hospital, France), in consecutive anterior ischemic stroke (AIS) patients ≤65 years old from a prospective stroke database. Using ASCOD phenotyping, ACIS patients were selected and cervical CTA were reviewed to find CaW. Among 1053 consecutive AIS patients, 266 ACIS patients with CTA were included. Among patients included (mean age 50, women 58%), CaW was in the ipsilateral carotid (iCaW) in 21 patients: 7.9% (95%CI [4.6-11.1]), (mean age 51, 11 women, 16 Caucasian). iCaW were uncovered during study review of CTA in 6/21 (29%) patients. Comparison between patients with iCaW and those without iCaW showed no differences except that of a higher rate of intracranial large vessel occlusion (LVO) (62.4 vs 37.6%; p = 0.03). Patients with iCaW under conservative medical therapy had an annualized stroke recurrence rate (SRR) of 11.4% (95%CI [8.4-15.1]. iCaW was identified as a source of stroke in about 8% of a French population ≤65 years with ACIS. iCaW was associated with a higher rate of LVO and a high SRR under conservative medical therapy.

Sections du résumé

BACKGROUND AND PURPOSE
Carotid webs (CaW) may be an under-recognized cause of anterior circulation cryptogenic ischemic stroke (ACIS). Prevalence is still unknown in European patients with ACIS.
OBJECTIVE
To evaluate the prevalence of CaW in ACIS and describe patients with CaW phenotype in a cohort of patients from a French stroke center.
METHODS
We conducted a retrospective monocentric cohort study from 01/01/2015 to 31/12/2019 (Montpellier University Hospital, France), in consecutive anterior ischemic stroke (AIS) patients ≤65 years old from a prospective stroke database. Using ASCOD phenotyping, ACIS patients were selected and cervical CTA were reviewed to find CaW.
RESULTS
Among 1053 consecutive AIS patients, 266 ACIS patients with CTA were included. Among patients included (mean age 50, women 58%), CaW was in the ipsilateral carotid (iCaW) in 21 patients: 7.9% (95%CI [4.6-11.1]), (mean age 51, 11 women, 16 Caucasian). iCaW were uncovered during study review of CTA in 6/21 (29%) patients. Comparison between patients with iCaW and those without iCaW showed no differences except that of a higher rate of intracranial large vessel occlusion (LVO) (62.4 vs 37.6%; p = 0.03). Patients with iCaW under conservative medical therapy had an annualized stroke recurrence rate (SRR) of 11.4% (95%CI [8.4-15.1].
CONCLUSIONS
iCaW was identified as a source of stroke in about 8% of a French population ≤65 years with ACIS. iCaW was associated with a higher rate of LVO and a high SRR under conservative medical therapy.

Identifiants

pubmed: 34098374
pii: S0022-510X(21)00207-0
doi: 10.1016/j.jns.2021.117513
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117513

Informations de copyright

Copyright © 2021 Elsevier B.V. All rights reserved.

Auteurs

C Turpinat (C)

Unité Neurovasculaire, Département de Neurologie, Hôpital Gui de Chauliac, Montpellier, France.

F L Collemiche (FL)

Département de Neuroradiologie diagnostique et thérapeutique, Hôpital Gui de Chauliac, Montpellier, France.

C Arquizan (C)

Unité Neurovasculaire, Département de Neurologie, Hôpital Gui de Chauliac, Montpellier, France.

N Molinari (N)

IMAG, CNRS, Univ Montpellier, CHU, Montpellier, France.

F Cagnazzo (F)

Département de Neuroradiologie diagnostique et thérapeutique, Hôpital Gui de Chauliac, Montpellier, France.

I Mourand (I)

Unité Neurovasculaire, Département de Neurologie, Hôpital Gui de Chauliac, Montpellier, France.

P H Lefèvre (PH)

Département de Neuroradiologie diagnostique et thérapeutique, Hôpital Gui de Chauliac, Montpellier, France.

P Henneton (P)

Service de Médecine Vasculaire et angiologie, Département de Médecine Interne, Hopital Saint Eloi, Montpellier, France.

L Corti (L)

Unité Neurovasculaire, Département de Neurologie, Hôpital Gui de Chauliac, Montpellier, France.

G Gascou (G)

Département de Neuroradiologie diagnostique et thérapeutique, Hôpital Gui de Chauliac, Montpellier, France.

I Derraz (I)

Département de Neuroradiologie diagnostique et thérapeutique, Hôpital Gui de Chauliac, Montpellier, France.

S Olindo (S)

Unité Neurovasculaire, Département de Neurologie, Hôpital Pellegrin, Bordeaux, France.

V Costalat (V)

Département de Neuroradiologie diagnostique et thérapeutique, Hôpital Gui de Chauliac, Montpellier, France.

C Dargazanli (C)

Département de Neuroradiologie diagnostique et thérapeutique, Hôpital Gui de Chauliac, Montpellier, France.

N Gaillard (N)

Unité Neurovasculaire, Département de Neurologie, Hôpital Gui de Chauliac, Montpellier, France. Electronic address: n-gaillard@chu-montpellier.fr.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH